Fig. 5From: Clinical outcomes of chemotherapy in patients with undifferentiated carcinoma of the pancreas: a retrospective multicenter cohort studyKaplan-Meier curves comparing overall survival in patients treated with a first-line paclitaxel-containing regimen and a non-paclitaxel-containing regimen (a), and comparing progression-free survival in patients treated with a paclitaxel-containing regimen and a non-paclitaxel-containing regimen in any line (b). OS, overall survival; PFS, progression-free survivalBack to article page